Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

NCT02647164 is registered in ClinicalTrials.gov with GenoSaber as lead sponsor.

NCT NCT02647164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02647164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring
Lead sponsor
GenoSaber
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
Not reported
Enrollment
360 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung carcinoma